vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Taylor Morrison Home Corp (TMHC). Click either name above to swap in a different company.

Taylor Morrison Home Corp is the larger business by last-quarter revenue ($1.4B vs $749.2M, roughly 1.9× CLOVER HEALTH INVESTMENTS, CORP.). Taylor Morrison Home Corp runs the higher net margin — 7.1% vs 3.6%, a 3.5% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs -26.8%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs -16.5%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Taylor Morrison is one of the largest home building companies in the United States. Its corporate headquarters are in Scottsdale, Arizona. The company formed when Taylor Woodrow and Morrison Homes joined forces in July 2007. Taylor Morrison operates in Arizona, California, Colorado, Georgia, Florida, North Carolina, South Carolina, Nevada, Indiana, and Texas, building mid-to-upscale housing, as well as first-time and mid-market homes.

CLOV vs TMHC — Head-to-Head

Bigger by revenue
TMHC
TMHC
1.9× larger
TMHC
$1.4B
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+88.9% gap
CLOV
62.0%
-26.8%
TMHC
Higher net margin
TMHC
TMHC
3.5% more per $
TMHC
7.1%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
-16.5%
TMHC

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLOV
CLOV
TMHC
TMHC
Revenue
$749.2M
$1.4B
Net Profit
$27.3M
$98.6M
Gross Margin
21.0%
Operating Margin
3.6%
Net Margin
3.6%
7.1%
Revenue YoY
62.0%
-26.8%
Net Profit YoY
-53.8%
EPS (diluted)
$0.05
$1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
TMHC
TMHC
Q1 26
$749.2M
$1.4B
Q4 25
$487.7M
$2.1B
Q3 25
$496.6M
$2.1B
Q2 25
$477.6M
$2.0B
Q1 25
$462.3M
$1.9B
Q4 24
$337.0M
$2.4B
Q3 24
$331.0M
$2.1B
Q2 24
$356.3M
$2.0B
Net Profit
CLOV
CLOV
TMHC
TMHC
Q1 26
$27.3M
$98.6M
Q4 25
$-49.3M
$174.0M
Q3 25
$-24.4M
$201.4M
Q2 25
$-10.6M
$193.6M
Q1 25
$-1.3M
$213.5M
Q4 24
$-22.1M
$242.5M
Q3 24
$-9.2M
$251.1M
Q2 24
$7.4M
$199.5M
Gross Margin
CLOV
CLOV
TMHC
TMHC
Q1 26
21.0%
Q4 25
22.0%
Q3 25
22.7%
Q2 25
23.0%
Q1 25
24.4%
Q4 24
23.9%
Q3 24
24.5%
25.0%
Q2 24
30.3%
23.7%
Operating Margin
CLOV
CLOV
TMHC
TMHC
Q1 26
3.6%
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
Q1 25
-0.3%
Q4 24
-6.4%
Q3 24
-2.7%
Q2 24
2.0%
Net Margin
CLOV
CLOV
TMHC
TMHC
Q1 26
3.6%
7.1%
Q4 25
-10.1%
8.3%
Q3 25
-4.9%
9.6%
Q2 25
-2.2%
9.5%
Q1 25
-0.3%
11.3%
Q4 24
-6.6%
10.3%
Q3 24
-2.8%
11.8%
Q2 24
2.1%
10.0%
EPS (diluted)
CLOV
CLOV
TMHC
TMHC
Q1 26
$0.05
$1.12
Q4 25
$1.77
Q3 25
$2.01
Q2 25
$1.92
Q1 25
$2.07
Q4 24
$2.29
Q3 24
$2.37
Q2 24
$1.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
TMHC
TMHC
Cash + ST InvestmentsLiquidity on hand
$177.6M
$652.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$339.4M
$6.2B
Total Assets
$697.7M
$9.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
TMHC
TMHC
Q1 26
$177.6M
$652.9M
Q4 25
$78.3M
$850.0M
Q3 25
$370.6M
Q2 25
$130.2M
Q1 25
$377.8M
Q4 24
$194.5M
$487.2M
Q3 24
$288.0M
$256.4M
Q2 24
$254.8M
$246.8M
Total Debt
CLOV
CLOV
TMHC
TMHC
Q1 26
Q4 25
$2.3B
Q3 25
$2.2B
Q2 25
$2.1B
Q1 25
$2.1B
Q4 24
$2.1B
Q3 24
$2.1B
Q2 24
$2.2B
Stockholders' Equity
CLOV
CLOV
TMHC
TMHC
Q1 26
$339.4M
$6.2B
Q4 25
$308.7M
$6.3B
Q3 25
$340.9M
$6.2B
Q2 25
$344.2M
$6.1B
Q1 25
$336.1M
$6.0B
Q4 24
$341.1M
$5.9B
Q3 24
$342.2M
$5.7B
Q2 24
$324.9M
$5.5B
Total Assets
CLOV
CLOV
TMHC
TMHC
Q1 26
$697.7M
$9.8B
Q4 25
$541.0M
$9.8B
Q3 25
$559.7M
$9.6B
Q2 25
$575.0M
$9.5B
Q1 25
$583.7M
$9.4B
Q4 24
$580.7M
$9.3B
Q3 24
$653.0M
$9.3B
Q2 24
$674.2M
$9.1B
Debt / Equity
CLOV
CLOV
TMHC
TMHC
Q1 26
Q4 25
0.36×
Q3 25
0.35×
Q2 25
0.35×
Q1 25
0.35×
Q4 24
0.36×
Q3 24
0.37×
Q2 24
0.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

TMHC
TMHC

Home closings revenue, net$1.3B95%
Financial services revenue, net$49.3M4%
Land closings revenue$14.5M1%
Amenity and other revenue$11.9M1%

Related Comparisons